137 related articles for article (PubMed ID: 37348608)
1. Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study.
Walls GM; O'Connor J; Harbinson M; McCarron EP; Duane F; McCann C; McKavanagh P; Johnston DI; Erekkath J; Giacometti V; Gavin AT; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
Radiother Oncol; 2023 Sep; 186():109762. PubMed ID: 37348608
[TBL] [Abstract][Full Text] [Related]
2. The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study.
Walls GM; O'Connor J; Harbinson M; Duane F; McCann C; McKavanagh P; Johnston DI; Giacometti V; McAleese J; Hounsell AR; Cole AJ; Butterworth KT; McGarry CK; Hanna GG; Jain S
Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):119-127. PubMed ID: 38042669
[TBL] [Abstract][Full Text] [Related]
3. Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer.
Atkins KM; Bitterman DS; Chaunzwa TL; Williams CL; Rahman R; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Pract Radiat Oncol; 2021; 11(5):e459-e467. PubMed ID: 33476841
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis.
Walls GM; McCann C; O'Connor J; O'Sullivan A; I Johnston D; McAleese J; McGarry CK; Cole AJ; Jain S; Butterworth KT; Hanna GG
Radiother Oncol; 2024 Mar; 192():110085. PubMed ID: 38184145
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
Dess RT; Sun Y; Matuszak MM; Sun G; Soni PD; Bazzi L; Murthy VL; Hearn JWD; Kong FM; Kalemkerian GP; Hayman JA; Ten Haken RK; Lawrence TS; Schipper MJ; Jolly S
J Clin Oncol; 2017 May; 35(13):1395-1402. PubMed ID: 28301264
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study.
Donovan EK; Pond GR; Seow H; Ellis PM; Swaminath A
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e182-e188. PubMed ID: 36535850
[TBL] [Abstract][Full Text] [Related]
9. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.
Wang K; Pearlstein KA; Patchett ND; Deal AM; Mavroidis P; Jensen BC; Lipner MB; Zagar TM; Wang Y; Lee CB; Eblan MJ; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
Radiother Oncol; 2017 Nov; 125(2):293-300. PubMed ID: 29050957
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC.
Yegya-Raman N; Wang K; Kim S; Reyhan M; Deek MP; Sayan M; Li D; Patel M; Malhotra J; Aisner J; Marks LB; Jabbour SK
J Thorac Oncol; 2018 Oct; 13(10):1508-1518. PubMed ID: 29883836
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
[TBL] [Abstract][Full Text] [Related]
13. Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
Chan ST; Ruan D; Shaverdian N; Raghavan G; Cao M; Lee P
Clin Lung Cancer; 2020 Mar; 21(2):136-144.e1. PubMed ID: 31932217
[TBL] [Abstract][Full Text] [Related]
14. High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients.
Cantini L; Pecci F; Hurkmans DP; Belderbos RA; Lanese A; Copparoni C; Aerts S; Cornelissen R; Dumoulin DW; Fiordoliva I; Rinaldi S; Aerts JGJV; Berardi R
Eur J Cancer; 2021 Feb; 144():41-48. PubMed ID: 33326868
[TBL] [Abstract][Full Text] [Related]
15. Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer.
Contreras JA; Lin AJ; Weiner A; Speirs C; Samson P; Mullen D; Campian J; Bradley J; Roach M; Robinson C
Radiother Oncol; 2018 Sep; 128(3):498-504. PubMed ID: 29859754
[TBL] [Abstract][Full Text] [Related]
16. Impact of Statin Use on Recurrence or Survival After Surgical Curative Resection of Non-Small Cell Lung Cancer.
Oh TK; Kim K; Jheon S; Lee J; Do SH; Hwang JW; Kim HJ; Song IA
Cancer Control; 2018; 25(1):1073274818778000. PubMed ID: 29781295
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.
Hawkins PG; Sun Y; Dess RT; Jackson WC; Sun G; Bi N; Tewari M; Hayman JA; Kalemkerian GP; Gadgeel SM; Lawrence TS; Haken RKT; Matuszak MM; Kong FS; Schipper MJ; Jolly S
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1635-1643. PubMed ID: 30923943
[TBL] [Abstract][Full Text] [Related]
18. A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study.
Takada K; Shimokawa M; Takamori S; Shimamatsu S; Hirai F; Tagawa T; Okamoto T; Hamatake M; Tsuchiya-Kawano Y; Otsubo K; Inoue K; Yoneshima Y; Tanaka K; Okamoto I; Nakanishi Y; Mori M
BMC Cancer; 2022 May; 22(1):503. PubMed ID: 35524214
[TBL] [Abstract][Full Text] [Related]
19. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
20. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
